FDA Approved: OXYBUTYNIN — Original Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved the original ANDA for oxybutynin from Zydus Pharmaceuticals USA Inc., authorizing a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• oxybutynin (oxybutynin)

Snippet

ORIG AP for OXYBUTYNIN (OXYBUTYNIN)